Key result
ACE-inhibitor therapy was suspected to induce laryngeal angioedema, a condition that occasionally causes severe airway edema and potential suffocation.
This case report highlights a suspected instance of ACE-inhibitor-induced laryngeal angioedema, a potentially life-threatening adverse event.
Basic definition of angioedema highlights airway risk; leaves open questions on classification and targeted management.
Angioedema, a deep-seated edema that appears in localized areas of the skin and mucous membranes, could be classified as urticaria in a broad sense, but in contrast to normal urticaria, is not accompanied by erythema and pruritus. It occurs most commonly on the face, especially involving the lips and eyelids, and occasionally causes airway edema, which could cause suffocation.
No takes yet. Share an insight, caveat, or question.
Kawaura et al. (2021) studied this question. ACE-inhibitor therapy was suspected to induce laryngeal angioedema, a condition that occasionally causes severe airway edema and potential suffocation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: